The Online Investor
OLI Premium
Retiree Portfolio
Stock Option Ideas
Preferred Stock Newsletter

Slideshow Secondary Stock Offerings

By The Online Investor Staff, updated Sat., Oct. 22, 9:22 AM

Slide #21. AxoGen, Inc. Secondary Offering

Company: AxoGen, Inc. (NASDAQ:AXGN)
Date announced: 10/6/2016
Shares Offered: 2,333,334
Date of Pricing: 10/7/2016
Price Per Share: $7.50
Secondary Offering Details: AxoGen, Inc. (NASDAQ:AXGN), a global leader in innovative surgical solutions for peripheral nerve injuries, today announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock in an underwritten public offering. -updated 10/7- AxoGen, Inc. (NASDAQ:AXGN), a global leader in innovative surgical solutions for peripheral nerve injuries, today announced the pricing of an underwritten public offering of 2,333,334 shares of its common stock, offered at a price to the public of $7.50 per share. The gross proceeds to AxoGen from this offering are expected to be approximately $17.5 million, before deducting underwriting discounts and commissions and other estimated offering expenses payable by AxoGen. In addition, the Company has granted the underwriters a 30-day option to purchase up to 350,000 additional shares of its common stock. The offering is expected to close on or about October 12, 2016, subject to customary closing conditions.

Axogen is a medical technology company focused on peripheral nerve repair. Co.'s products include: Avance® Nerve Graft, which is developed for the surgical repair of peripheral nerve discontinuities to support regeneration across the defect; AxoGuard® Nerve Connector, which is a coaptation aid used to align and connect severed nerve ends in a tensionless repair; AxoGuard® Nerve Protector, which is used to wrap injured peripheral nerves and reinforce reconstructed nerve gaps; AcroVal™ Neurosensory and Motor Testing System, which is a device for evaluating patients with peripheral nerve conditions; and AxoTouch™ Two Point Discriminator, which helps healthcare personnel in sensibility testing.

AXGN SEC Filing Email Alerts Service

Open the AXGN Page at The Online Investor »

Company Name:  AxoGen Inc
Sector:  Medical Instruments & Supplies
Number of ETFs Holding AXGN:  13
Total Market Value Held by ETFs:  $6.99M
Total Market Capitalization:  $268.00M
% of Market Cap. Held by ETFs:  2.61%

Open the AXGN Page at The Online Investor (in a new window) »

October 22, 2016    9:22 AM Eastern
Quotes delayed 20 minutes

Buy (3.33 out of 4)
62nd percentile
(ranked higher than approx. 62% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Secondary Stock Offerings | | Copyright © 1998 - 2016, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.